SCHEMBL29473693

SCHEMBL29473693

CC(C)C[C@H](NC(=O)[C@H](CS)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)O

nearest known ligand 0.44

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ GRIN2D O15399 1/20 0.44
▸ GRIN3B O60391 1/20 0.44
▸ GRIN1 Q05586 1/20 0.44
▸ GRIN2A Q12879 1/20 0.44
▸ GRIN2B Q13224 1/20 0.44
▸ GRIN2C Q14957 1/20 0.44
▸ GRIN3A Q8TCU5 1/20 0.44
▸ KISS1R Q969F8 15/20 0.43
▸ NPY1R P25929 1/20 0.43
▸ NPY2R P49146 1/20 0.43
▸ NPY4R P50391 1/20 0.43
▸ NMT2 O60551 1/20 0.42
▸ NMT1 P30419 1/20 0.42
▸ OPRD1 P41143 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30484829 0.93 NPY1R (0.42) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL29473689 0.91 NPY4R (0.42) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL29473686 0.91 NMT2 (0.47) NPY1RNPY2RNPY4RNMT2NMT1
SCHEMBL29473690 0.90 GRIN2D (0.47) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL30484834 0.89 NPY4R (0.47) NPY1RNPY2RNPY4RNMT2NMT1
SCHEMBL30924756 0.89 GRIN2D (0.43) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL30484828 0.88 MME (0.47) NPY1RNPY2RNPY4RNMT2NMT1
SCHEMBL30484831 0.88 NPY4R (0.46) NPY1RNPY2RNPY4RNMT2NMT1
SCHEMBL30484833 0.88 NPY4R (0.44) NPY1RNPY2RNPY4RNMT2NMT1
SCHEMBL29886546 0.88 NMT1 (0.47) NPY1RNPY2RNPY4RNMT2NMT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4216992-A1 PARTICLE COMPRISING AN RSV-F PROTEIN FOR USE IN RSV VACCINATION DBV Technologies (FR) 2023-08-02 — — EP disclosed
WO-2022063990-A1 PARTICLE COMPRISING AN RSV-F PROTEIN FOR USE IN RSV VACCINATION DBV TECHNOLOGIES (FR) 2022-03-31 — — WO disclosed
Send feedback